Non-Compartmental and Compartmental Approaches to Pharmacokinetic Data Analysis
暂无分享,去创建一个
[1] Kiyoshi Yamaoka,et al. Statistical moments in pharmacokinetics , 1978, Journal of Pharmacokinetics and Biopharmaceutics.
[2] Y. Sugiyama,et al. Modulation of the tumor disposition of vinca alkaloids by PSC 833 in vitro and in vivo. , 1998, The Journal of pharmacology and experimental therapeutics.
[3] K. Zierler. Theory of Use of Indicators to Measure Blood Flow and Extracellular Volume and Calculation of Transcapillary Movement of Tracers , 1963 .
[4] Charles DeLisi,et al. Mean residence time—theoretical development, experimental determination, and practical use in tracer analysis☆ , 1984 .
[5] J J DiStefano,et al. Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations. , 1984, The American journal of physiology.
[6] Comments on mean residence time determination , 1985, Journal of Pharmacokinetics and Biopharmaceutics.
[7] P Veng-Pedersen,et al. Noncompartmentally-based pharmacokinetic modeling. , 2001, Advanced drug delivery reviews.
[8] Malcolm Rowland,et al. Clinical pharmacokinetics : concepts and applications , 1989 .
[9] Claudio Cobelli,et al. Tracer Kinetics in Biomedical Research: From Data to Model , 2013 .
[10] M Berman,et al. Kinetic analysis of turnover data. , 1979, Progress in biochemical pharmacology.
[11] L. Benet. Clearance (née Rowland) concepts: a downdate and an update , 2010, Journal of Pharmacokinetics and Pharmacodynamics.
[12] K. C. Yeh,et al. A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation , 1978, Journal of Pharmacokinetics and Biopharmaceutics.
[13] M. Weiss,et al. Pharmacokinetic model based on circulatory transport , 1979, European Journal of Clinical Pharmacology.
[14] J J DiStefano,et al. Multiexponential, multicompartmental, and noncompartmental modeling. I. Methodological limitations and physiological interpretations. , 1984, The American journal of physiology.
[15] A. Rescigno,et al. Estimation of Permanence Time, Exit Time, Dilution Factor, and Steady-State Volume of Distribution , 2004, Pharmaceutical Research.
[16] Fundamental concepts in pharmacokinetics. , 1997, Pharmacological research.
[17] J N Weinstein,et al. Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice. , 1986, Cancer research.
[18] J J Distefano,et al. DIMSUM: an expert system for multiexponential model discrimination. , 1992, The American journal of physiology.
[19] S. Beal. Some clarifications regarding moments of residence times with pharmacokinetic models , 1987, Journal of Pharmacokinetics and Biopharmaceutics.
[20] K. Zierler,et al. THEORY OF THE USE OF ARTERIOVENOUS CONCENTRATION DIFFERENCES FOR MEASURING METABOLISM IN STEADY AND NON-STEADY STATES. , 1961, The Journal of clinical investigation.
[21] W R Gillespie,et al. Noncompartmental Versus Compartmental Modelling in Clinical Pharmacokinetics , 1991, Clinical pharmacokinetics.
[22] R. Hansen,et al. Antibody pharmacokinetics and pharmacodynamics. , 2004, Journal of pharmaceutical sciences.
[23] R. Purves,et al. Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC) , 1992, Journal of Pharmacokinetics and Biopharmaceutics.
[24] J J DiStefano,et al. Noncompartmental vs. compartmental analysis: some bases for choice. , 1982, The American journal of physiology.
[25] R. Schoenfeld,et al. Invariants in Experimental Data on Linear Kinetics and the Formulation of Models , 1956 .
[26] J. Wagner. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data , 1976, Journal of Pharmacokinetics and Biopharmaceutics.
[27] Karl Pearson,et al. ON THE SYSTEMATIC FITTING OF CURVES TO OBSERVATIONS AND MEASUREMENTS , 1902 .
[28] C. Cobelli,et al. Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. , 1980, The American journal of physiology.
[29] F P Chinard,et al. Indicator equivalence theorem for input rates and regional masses in multi-inlet steady-state systems with partially labeled input. , 1969, Journal of theoretical biology.
[30] D. Katz,et al. Experimental design for estimating integrals by numerical quadrature, with applications to pharmacokinetic studies. , 1983, Biometrics.
[31] M. Weiss,et al. Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts , 2007, The AAPS Journal.
[32] A Rescigno,et al. The rise and fall of compartmental analysis. , 2001, Pharmacological research.
[33] C Cobelli,et al. Compartmental vs. noncompartmental modeling for two accessible pools. , 1984, The American journal of physiology.
[34] K. Norwich. Noncompartmental models of whole-body clearance of tracers: A review , 1997, Annals of Biomedical Engineering.
[35] Ivan Nestorov,et al. Whole Body Pharmacokinetic Models , 2003, Clinical pharmacokinetics.
[36] Joseph J. DiStefanoIII. Concepts, properties, measurement, and computation of clearance rates of hormones and other substances in biological systems , 1976 .
[37] John A. Jacquez,et al. Qualitative Theory of Compartmental Systems , 1993, SIAM Rev..
[38] J. Jacquez. Compartmental analysis in biology and medicine , 1985 .
[39] D. Mager. Target-mediated drug disposition and dynamics. , 2006, Biochemical pharmacology.
[40] A Mari,et al. Circulatory models of intact-body kinetics and their relationship with compartmental and non-compartmental analysis. , 1993, Journal of theoretical biology.
[41] Johan Gabrielsson,et al. Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications , 2002 .
[42] M. Weiss,et al. The relevance of residence time theory to pharmacokinetics , 2005, European Journal of Clinical Pharmacology.
[43] A. John Bailer,et al. Testing for the equality of area under the curves when using destructive measurement techniques , 1988, Journal of Pharmacokinetics and Biopharmaceutics.